LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 26

Search options

  1. Article: Chronology of the Youfang site and its implications for the emergence of microblade technology in North China

    Nian, Xiaomei / Fei Xie / Huijie Mei / Liping Zhou / Xing Gao

    Quaternary international. 2014 Oct. 09, v. 347

    2014  

    Abstract: The Youfang Paleolithic site, located in the eastern Nihewan Basin, Hebei Province, China, was ... The results suggest that human occupation at the Youfang site ranged from ca. 26 ka to 29 ka. Indeed ...

    Abstract The Youfang Paleolithic site, located in the eastern Nihewan Basin, Hebei Province, China, was discovered in 1984. However, the microblade assemblages which were excavated from the site lacked reliable chronological data. In this study, an optical dating technique was applied to nine samples from Late Pleistocene eolian sequences at the site. The ages of three samples from artifact-bearing deposits were in the range of ca. 26–29 ka with depths between 2.1 m and 2.9 m obtained with medium-grained quartz, corresponding to Marine Isotope Stage 3 (MIS3). These displayed evidence of a longer-term climate trend, in which the climate became gradually warmer and more humid. The sample from the upper culture layer was dated to 26.4 ± 2.1 ka. Five samples taken from the lower culture layer yielded ages between ca. 28 ka and 43 ka. The results suggest that human occupation at the Youfang site ranged from ca. 26 ka to 29 ka. Indeed, the Nihewan Basin yields the oldest microblade site in northern high latitudes (40° N), and offers a unique opportunity to study the emergence and characteristics of microblade technologies in northeast Asia. Nevertheless, extensive archeological field surveys and excavations are still needed to understand further the developmental process of microblade technologies in the region.
    Keywords basins ; climate ; humans ; latitude ; paleoclimatology ; quartz ; surveys ; China
    Language English
    Dates of publication 2014-1009
    Size p. 113-121.
    Publishing place Elsevier Ltd
    Document type Article
    ISSN 1040-6182
    DOI 10.1016/j.quaint.2014.05.053
    Database NAL-Catalogue (AGRICOLA)

    More links

    Kategorien

  2. Article ; Online: Clinical Features and Treatment Protocol in Eleven Chinese Children with Mild COVID-19.

    Gao, Youfang / Zhang, Dongfeng / Sui, Sumin / Xu, Renying

    Indian journal of pediatrics

    2020  Volume 87, Issue 9, Page(s) 748

    Keywords covid19
    Language English
    Publishing date 2020-06-04
    Publishing country India
    Document type Letter ; Comment
    ZDB-ID 218231-2
    ISSN 0973-7693 ; 0019-5456
    ISSN (online) 0973-7693
    ISSN 0019-5456
    DOI 10.1007/s12098-020-03352-6
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article: Development and validation of a disulfidptosis and disulfide metabolism-related risk index for predicting prognosis in lung adenocarcinoma.

    Zhong, Leqi / Chang, Wuguang / Luo, Bin / Gao, Wuyou / He, Huanhuan / Fang, Mouxiang / Li, Hongmu / Wen, Zhesheng / Chen, Youfang

    Cancer cell international

    2024  Volume 24, Issue 1, Page(s) 2

    Abstract: Background: Disulfidptosis is a recently proposed novel cell death mode in which cells with high SLC7A11 expression induce disulfide stress and cell death in response to glucose deficiency. The purpose of the research was to explore the function of ... ...

    Abstract Background: Disulfidptosis is a recently proposed novel cell death mode in which cells with high SLC7A11 expression induce disulfide stress and cell death in response to glucose deficiency. The purpose of the research was to explore the function of disufidptosis and disulfide metabolism in the progression of lung adenocarcinoma (LUAD).
    Methods: The RNA-seq data from TCGA were divided into high/low expression group on the base of the median expression of SLC7A11, and the characteristic of differentially expressed disulfide metabolism-related genes. Least absolute shrinkage and selection operator (LASSO) algorithm was conducted the disulfidptosis and disulfide metabolism risk index. The tumor mutation burden (TMB), mechanism, pathways, tumor microenvironment (TME), and immunotherapy response were assessed between different risk groups. The role of TXNRD1 in LUAD was investigated by cytological experiments.
    Results: We established the risk index containing 5 genes. There are significant differences between different risk groups in terms of prognosis, TMB and tumor microenvironment. Additionally, the low-risk group demonstrated a higher rate of response immunotherapy in the prediction of immunotherapy response. Experimental validation suggested that the knockdown of TXNRD1 suppressed cell proliferation, migration, and invasion of LUAD.
    Conclusion: Our research highlights the enormous potential of disulfidptosis and disulfide metabolism risk index in predicting the prognosis of LUAD. And TXNRD1 has great clinical translational ability.
    Language English
    Publishing date 2024-01-02
    Publishing country England
    Document type Journal Article
    ZDB-ID 2091573-1
    ISSN 1475-2867
    ISSN 1475-2867
    DOI 10.1186/s12935-023-03204-1
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Overexpression of PSAT1 is Correlated with Poor Prognosis and Immune Infiltration in Non-Small Cell Lung Cancer.

    Li, Hongmu / Wu, Chun / Chang, Wuguang / Zhong, Leqi / Gao, Wuyou / Zeng, Mingyue / Wen, Zhesheng / Mai, Shijuan / Chen, Youfang

    Frontiers in bioscience (Landmark edition)

    2023  Volume 28, Issue 10, Page(s) 243

    Abstract: Purpose: Current evidence suggests that phosphoserine aminotransferase 1 (: Methods: The expression profile of : Results: Analysis of transcriptional expression profiles using TCGA data revealed overexpression of : Conclusions: ... ...

    Abstract Purpose: Current evidence suggests that phosphoserine aminotransferase 1 (
    Methods: The expression profile of
    Results: Analysis of transcriptional expression profiles using TCGA data revealed overexpression of
    Conclusions: PSAT1
    MeSH term(s) Humans ; Carcinoma, Non-Small-Cell Lung/genetics ; Cell Line ; Cell Proliferation/genetics ; Immunotherapy ; Lung Neoplasms/genetics ; Tumor Microenvironment/genetics
    Chemical Substances PSAT1 protein, human (EC 2.6.1.52)
    Language English
    Publishing date 2023-11-02
    Publishing country Singapore
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2704569-9
    ISSN 2768-6698 ; 2768-6698
    ISSN (online) 2768-6698
    ISSN 2768-6698
    DOI 10.31083/j.fbl2810243
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article: Retinopathy as a predictive indicator for significant hepatic fibrosis according to T2DM status: A cross-sectional study based on the national health and nutrition examination survey data.

    Li, Jinze / Xiang, Yi / Han, Jiahao / Gao, Youfang / Wang, Ruiying / Dong, Zihe / Chen, Huihui / Gao, Ruixia / Liu, Chuan / Teng, Gao-Jun / Qi, Xiaolong

    Annals of hepatology

    2024  Volume 29, Issue 4, Page(s) 101478

    Abstract: Introduction and objectives: Type 2 Diabetes Mellitus (T2DM), a prevalent metabolic disorder, often coexists with a range of complications, with retinopathy being particularly common. Recent studies have shed light on a potential connection between ... ...

    Abstract Introduction and objectives: Type 2 Diabetes Mellitus (T2DM), a prevalent metabolic disorder, often coexists with a range of complications, with retinopathy being particularly common. Recent studies have shed light on a potential connection between diabetic retinopathy (DR) and hepatic fibrosis, indicating a possible shared pathophysiological foundation in T2DM. This study investigates the correlation between retinopathy and hepatic fibrosis among individuals with T2DM, as well as evaluates the diagnostic value of DR for significant hepatic fibrosis.
    Materials and methods: Our cross-sectional analysis incorporated 5413 participants from the National Health and Nutrition Examination Survey (NHANES) 2005-2008. The Fibrosis-4 score (FIB-4) classified hepatic fibrosis into different grades (F0-F4), with significant hepatic fibrosis marked as F2 or higher. Retinopathy severity was determined using retinal imaging and categorized into four levels. The analysis of variance or Chi-square tests facilitated group comparisons. Additionally, the receiver operating characteristic (ROC) analysis appraised the predictive accuracy of retinopathy for significant hepatic fibrosis in the T2DM population.
    Results: Among 5413 participants, the mean age was 59.56 ± 12.41, with 50.2% male. And 20.6% were diagnosed with T2DM. Hepatic fibrosis grading was positively associated with retinopathy severity (OR [odds ratio]: 1.521, 95%CI [confidence interval]: 1.152-2.008, P = 0.003) across the entire population. The association was amplified in the T2DM population according to Pearson's analysis results. The ROC curve demonstrated retinopathy's diagnostic capacity for significant hepatic fibrosis in the T2DM population (AUC [area under curve] = 0.72, 95%CI: 0.651-0.793, P < 0.001).
    Conclusions: Retinopathy could serve as an independent predictor of significant hepatic fibrosis in T2DM population. Ophthalmologists are advised to closely monitor T2DM patients with retinopathy.
    Language English
    Publishing date 2024-02-12
    Publishing country Mexico
    Document type Journal Article
    ZDB-ID 2188733-0
    ISSN 1665-2681
    ISSN 1665-2681
    DOI 10.1016/j.aohep.2024.101478
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Inhibiting miR-182-3p Alleviates Gestational Diabetes Mellitus by Improving Insulin Resistance in Skeletal Muscle

    Jinghong Rao / Youfang Chen / Jingying Huang / Ruoying Wu / Zhenzhu Dong / Yuling Gao / Xuan Chen

    Balkan Medical Journal, Vol 39, Iss 2, Pp 121-

    2022  Volume 129

    Abstract: Background: Gestational diabetes mellitus (GDM) is one of the most common metabolic diseases occurring during pregnancy. MiR-182- 3p participates in a variety of physiological processes such as cell proliferation, apoptosis, differentiation, and ... ...

    Abstract Background: Gestational diabetes mellitus (GDM) is one of the most common metabolic diseases occurring during pregnancy. MiR-182- 3p participates in a variety of physiological processes such as cell proliferation, apoptosis, differentiation, and migration5, but its role in GDM is largely unknown. Aims: To investigate the relationship between miRNA-182-3p and GDM and explore a potential therapeutic strategy for GDM. Study Design: Animal experimentation Methods: To evaluate the effect of miRNA182-3p in GDM, mice were separated as negative control (NC), miRNA-182-3p mimic or miRNA-182-3p inhibitor, and miRNAs were administered intraperitoneally. Additionally, miRNA-182-3p mimic or miRNA-182-3p inhibitor was transfected into C2C12 cells to evaluate glucose metabolism and insulin-related pathways. Results: The miR-182-3p mimic accelerated GDM, which was effectively reversed by the inhibitor in GDM mice (P = 0.005, miR- 182-3p inhibitor vs. mimic). Insulin receptor 1 (INSR1) was predicted to be the direct target gene of miR-182-3p using online tools. In addition, the miR-182-3p mimic inhibited INSR1 expression and insulin-related pathways in vivo and in vitro, which were all reversed by the miRNA82-3p inhibitor. Furthermore, the miR-182-3p mimic impaired glucose uptake and consumption by inhibiting translocation of glucose transporter type 4 (GLUT4) toward the C2C12 cell membrane (P = 0.007 vs. control), while the inhibitor accelerated these processes (P = 0.032 vs. control; P = 0.005, miRNA-182-3p inhibitor vs. mimic). Conclusion: Inhibiting miR-182-3p effectively alleviated the development of GDM through INSR1, suggesting a potential therapeutic strategy for GDM.
    Keywords Medicine ; R
    Language English
    Publishing date 2022-03-01T00:00:00Z
    Publisher Galenos Publishing House
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  7. Article ; Online: Transcriptomic Profiling of Meat Quality Traits of Skeletal Muscles of the Chinese Indigenous Huai Pig and Duroc Pig.

    Li, Xiaojin / Lu, Liangyue / Tong, Xinwei / Li, Ruidong / Jin, Erhui / Ren, Man / Gao, Yafei / Gu, Youfang / Li, Shenghe

    Genes

    2023  Volume 14, Issue 8

    Abstract: The Huai pig is a well-known indigenous pig breed in China. The main advantages of Huai pigs over Western commercial pig breeds include a high intramuscular fat (IMF) content and good meat quality. There are significant differences in the meat quality ... ...

    Abstract The Huai pig is a well-known indigenous pig breed in China. The main advantages of Huai pigs over Western commercial pig breeds include a high intramuscular fat (IMF) content and good meat quality. There are significant differences in the meat quality traits of the same muscle part or different muscle parts of the same variety. To investigate the potential genetic mechanism underlying the meat quality differences in different pig breeds or muscle groups, longissimus dorsi (LD), psoas major (PM), and biceps femoris (BF) muscle tissues were collected from two pig breeds (Huai and Duroc). There were significant differences in meat quality traits and amino acid content. We assessed the muscle transcriptomic profiles using high-throughput RNA sequencing. The IMF content in the LD, PM, and BF muscles of Huai pigs was significantly higher than that in Duroc pigs (
    MeSH term(s) Animals ; Amino Acids/analysis ; Amino Acids/biosynthesis ; Amino Acids/genetics ; China ; Food Quality ; Meat/standards ; Muscle Fibers, Skeletal/chemistry ; Muscle Fibers, Skeletal/metabolism ; Paraspinal Muscles/chemistry ; Paraspinal Muscles/metabolism ; Swine/genetics ; Transcriptome/genetics
    Chemical Substances Amino Acids
    Language English
    Publishing date 2023-07-28
    Publishing country Switzerland
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2527218-4
    ISSN 2073-4425 ; 2073-4425
    ISSN (online) 2073-4425
    ISSN 2073-4425
    DOI 10.3390/genes14081548
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Inhibiting miR-182-3p Alleviates Gestational Diabetes Mellitus by Improving Insulin Resistance in Skeletal Muscle.

    Rao, Jinghong / Chen, Youfang / Huang, Jingying / Wu, Ruoying / Dong, Zhenzhu / Gao, Yuling / Chen, Xuan

    Balkan medical journal

    2022  Volume 39, Issue 2, Page(s) 121–129

    Abstract: Background: Gestational diabetes mellitus (GDM) is one of the most common metabolic diseases occurring during pregnancy. MiR-182-3p participates in a variety of physiological processes such as cell proliferation, apoptosis, differentiation, and ... ...

    Abstract Background: Gestational diabetes mellitus (GDM) is one of the most common metabolic diseases occurring during pregnancy. MiR-182-3p participates in a variety of physiological processes such as cell proliferation, apoptosis, differentiation, and migration5, but its role in GDM is largely unknown.
    Aims: To investigate the relationship between miRNA-182-3p and GDM and explore a potential therapeutic strategy for GDM.
    Study design: Animal experimentation.
    Methods: To evaluate the effect of miRNA182-3p in GDM, mice were separated as negative control (NC), miRNA-182-3p mimic or miRNA-182-3p inhibitor, and miRNAs were administered intraperitoneally. Additionally, miRNA-182-3p mimic or miRNA-182-3p inhibitor was transfected into C2C12 cells to evaluate glucose metabolism and insulin-related pathways.
    Results: The miR-182-3p mimic accelerated GDM, which was effectively reversed by the inhibitor in GDM mice (
    Conclusion: Inhibiting miR-182-3p effectively alleviated the development of GDM through INSR1, suggesting a potential therapeutic strategy for GDM.
    MeSH term(s) Animals ; Diabetes, Gestational/genetics ; Diabetes, Gestational/metabolism ; Female ; Humans ; Insulin/metabolism ; Insulin/therapeutic use ; Insulin Resistance/genetics ; Mice ; MicroRNAs/genetics ; Muscle, Skeletal/metabolism ; Pregnancy
    Chemical Substances Insulin ; MicroRNAs ; Mirn182 microRNA, human ; Mirn182 microRNA, mouse
    Language English
    Publishing date 2022-02-25
    Publishing country Turkey
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2612982-6
    ISSN 2146-3131 ; 2146-3131
    ISSN (online) 2146-3131
    ISSN 2146-3131
    DOI 10.4274/balkanmedj.galenos.2021.2021-8-140
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Immune‐viral dynamics modeling for SARS‐CoV‐2 drug development

    Youfang Cao / Wei Gao / Luzelena Caro / Julie A. Stone

    Clinical and Translational Science, Vol 14, Iss 6, Pp 2348-

    2021  Volume 2359

    Abstract: Abstract Coronavirus disease 2019 (COVID‐19) global pandemic is caused by severe acute respiratory syndrome‐coronavirus 2 (SARS‐CoV‐2) viral infection, which can lead to pneumonia, lung injury, and death in susceptible populations. Understanding viral ... ...

    Abstract Abstract Coronavirus disease 2019 (COVID‐19) global pandemic is caused by severe acute respiratory syndrome‐coronavirus 2 (SARS‐CoV‐2) viral infection, which can lead to pneumonia, lung injury, and death in susceptible populations. Understanding viral dynamics of SARS‐CoV‐2 is critical for development of effective treatments. An Immune‐Viral Dynamics Model (IVDM) is developed to describe SARS‐CoV‐2 viral dynamics and COVID‐19 disease progression. A dataset of 60 individual patients with COVID‐19 with clinical viral load (VL) and reported disease severity were assembled from literature. Viral infection and replication mechanisms of SARS‐CoV‐2, viral‐induced cell death, and time‐dependent immune response are incorporated in the model to describe the dynamics of viruses and immune response. Disease severity are tested as a covariate to model parameters. The IVDM was fitted to the data and parameters were estimated using the nonlinear mixed‐effect model. The model can adequately describe individual viral dynamics profiles, with disease severity identified as a covariate on infected cell death rate. The modeling suggested that it takes about 32.6 days to reach 50% of maximum cell‐based immunity. Simulations based on virtual populations suggested a typical mild case reaches VL limit of detection (LOD) by 13 days with no treatment, a moderate case by 17 days, and a severe case by 41 days. Simulations were used to explore hypothetical treatments with different initiation time, disease severity, and drug effects to demonstrate the usefulness of such modeling in informing decisions. Overall, the IVDM modeling and simulation platform enables simulations for viral dynamics and treatment efficacy and can be used to aid in clinical pharmacokinetic/pharmacodynamic (PK/PD) and dose‐efficacy response analysis for COVID‐19 drug development.
    Keywords Therapeutics. Pharmacology ; RM1-950 ; Public aspects of medicine ; RA1-1270
    Subject code 610
    Language English
    Publishing date 2021-11-01T00:00:00Z
    Publisher Wiley
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

To top